Remove Bioinformatics Remove Marketing Remove Targeted Protein Degradation
article thumbnail

Evotec Achieves Key Milestones in Its Collaboration with Bristol Myers Squibb On Targeted Protein Degradation

The Pharma Data

Evotec and Bristol Myers Squibb (the successor in interest to Celgene ) initiated their long-term strategic drug discovery and development partnership in the field of targeted protein degradation in 2018 with the goal to identify novel drug targets.

article thumbnail

What to expect from SLAS Europe 2023

Drug Discovery World

Companies selected for Innovation AveNEW, and who opt-in to compete for the SLAS Ignite Award, will be judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential, funding prospects, plan for growth and the existence of balanced company leadership, among other qualities.